Ocular Tolerability and In Vivo Bioavailability of Poly(ethylene glycol) (PEG)‐Coated Polyethyl‐2‐Cyanoacrylate Nanosphere‐Encapsulated Acyclovir
- 1 March 2001
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 90 (3) , 288-297
- https://doi.org/10.1002/1520-6017(200103)90:3<288::aid-jps4>3.0.co;2-5
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Visualization of in vitro protein-rejecting properties of PEGylated stealth® polycyanoacrylate nanoparticlesBiomaterials, 1999
- Characterization and In-vivo Ocular Absorption of Liposome-encapsulated AcyclovirJournal of Pharmacy and Pharmacology, 1999
- Pefloxacine Mesilate- and Ofloxacin-Loaded Polyethylcyanoacrylate Nanoparticles: Characterization of the Colloidal Drug Carrier FormulationJournal of Pharmaceutical Sciences, 1995
- Intracellular accumulation of ofloxacin-loaded liposomes in human synovial fibroblastsAntimicrobial Agents and Chemotherapy, 1995
- Influence of enzymes on the stability of polybutylcyanoacrylate nanoparticlesInternational Journal of Pharmaceutics, 1994
- Design of New Formulations for Topical Ocular Administration: Polymeric Nanocapsules Containing MetipranololPharmaceutical Research, 1993
- Correlation of the surface hydrophobicity of 14C-poly(methyl methacrylate) nanoparticles to their body distributionJournal of Controlled Release, 1992
- Polyalkylcyanoacrylate nanoparticles as drug carrier: present state and perspectivesJournal of Controlled Release, 1991
- Pharmacokinetics and tolerance of acyclovir, a new anti-herpesvirus agent, in humansAntimicrobial Agents and Chemotherapy, 1982
- ACYCLOVIR INHIBITS HEPATITIS B VIRUS REPLICATION IN MANThe Lancet, 1982